Ryan Marth

Ryan Marth

Robins Kaplan LLP

Contact  |  View Bio  |  RSS

Latest Publications


After Actavis: Crafting Pharmaceutical Settlements that Avoid Antitrust Scrutiny

Last year’s Supreme Court decision in FTC v. Actavis cleared the way for more antitrust challenges to settlements between generic and branded pharmaceutical companies resolving Hatch-Waxman patent litigation. As a result,...more

7/11/2014 - Antitrust Litigation Corporate Counsel Enforcement Enforcement Actions FTC FTC v Actavis Hatch-Waxman Patent Litigation Patents Pharmaceutical Manufacturers Pharmaceutical Patents SCOTUS Settlement

Antitrust Bulletin - Vol. 5, No. 2

In this Issue: - Focus On The Federal Trade Commission - Supreme Court Decision in FTC v. Actavis Provides Guidance on Pay-for-Delay - DOJ Prevails on Liability in eBooks Antitrust Case in the Southern District...more

7/1/2013 - Actavis Inc. Dawn Raids DOJ EU FTC FTC v Actavis FTC v. Phoebe Putney Health System Hospital Mergers Pay-For-Delay Price-Fixing Reverse Payment Settlement Agreements SCOTUS State Action Doctrine Unfair Competition

2 Results
View per page
Page: of 1